Advertisement
Research Article

Potent Nonnucleoside Reverse Transcriptase Inhibitors Target HIV-1 Gag-Pol

  • Anna Figueiredo,

    Affiliations: Molecular Interactions Group, Macfarlane Burnet Institute for Medical Research and Public Health, Melbourne, Australia, Department of Microbiology, Monash University, Clayton, Australia

    X
  • Katie L Moore,

    Affiliation: Molecular Interactions Group, Macfarlane Burnet Institute for Medical Research and Public Health, Melbourne, Australia

    X
  • Johnson Mak,

    Affiliations: HIV Assembly Group, Macfarlane Burnet Institute for Medical Research and Public Health, Melbourne, Australia, Department of Biochemistry and Molecular Biology, Monash University, Clayton, Australia

    X
  • Nicolas Sluis-Cremer,

    Affiliation: Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, United States of America

    X
  • Marie-Pierre de Bethune,

    Affiliation: Tibotec Pharmaceuticals, Mechelen, Belgium

    X
  • Gilda Tachedjian mail

    To whom correspondence should be addressed. E-mail: gildat@burnet.edu.au

    Affiliations: Molecular Interactions Group, Macfarlane Burnet Institute for Medical Research and Public Health, Melbourne, Australia, Department of Microbiology, Monash University, Clayton, Australia, Department of Medicine, Monash University, Prahran, Australia

    X
  • Published: November 10, 2006
  • DOI: 10.1371/journal.ppat.0020119

Viewed info

Cited info

Saved info

Discussed info

Questions or concerns about usage data? Please let us know.